MAR

Marriott International, Inc.
$361.08
+4.58 (+1.28%)
Mkt Cap 94.16B
Volume 996,176
52W Range 256.76-410.98
Sector Consumer Cyclical
Beta 1.17
EPS (TTM) 9.60 USD
P/E Ratio 37.61
Revenue (TTM) 26.90B USD
Rev Growth (5Y) +19.9%
EPS Growth (5Y) +14.7%
AlphaVal · Fair Value
What we estimate one share is worth
$91.01
Overvalued strong signal
296.7% above fair value
Modeled from cash flows & growth.
AlphaQuality · Grade
How strong & durable the business is
A-
Platform & Compounding FCF
86.1 / 100 composite
A platform business that compounds free cash flow — graded A–F vs. similar companies.

Company Description

Track Record

Showing latest 4 periods • Swipe for more
Metric 2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014
Revenue 26.19B 25.10B 23.71B 20.77B 13.86B 10.57B 20.97B 20.76B 20.45B 15.41B 14.49B 13.80B
Net Income 2.60B 2.38B 3.08B 2.36B 1.10B (267.00M) 1.27B 1.91B 1.46B 808.00M 859.00M 753.00M
EPS 9.52 8.36 10.23 7.27 3.36 -0.82 3.83 5.16 3.89 2.78 3.22 2.60
Free Cash Flow 2.61B 2.00B 2.72B 2.03B 994.00M 1.50B 1.03B 1.80B 1.99B 1.42B 1.21B 813.00M
FCF / Share 9.71 7.03 9.01 6.26 3.04 4.62 3.10 5.14 5.30 4.88 4.53 2.80
Operating CF 3.21B 2.75B 3.17B 2.36B 1.18B 1.64B 1.69B 2.36B 2.23B 1.62B 1.51B 1.22B
Total Assets 27.54B 26.18B 25.67B 24.82B 25.55B 24.70B 25.05B 23.70B 23.95B 24.14B 6.08B 6.87B
Total Debt 17.08B 15.24B 12.76B 11.10B 11.24B 11.20B 11.82B 9.35B 8.24B 8.51B 4.11B 3.78B
Cash & Equiv 358.00M 396.00M 338.00M 507.00M 1.39B 877.00M 225.00M 316.00M 383.00M 858.00M 96.00M 104.00M
Book Value (3.77B) (2.99B) (682.00M) 568.00M 1.41B 430.00M 703.00M 2.23B 3.58B 5.36B (3.59B) (2.20B)
Return on Equity N/A N/A N/A 4.15 0.78 -0.62 1.81 0.86 0.41 0.15 N/A N/A
MAR News
The Rise of Place: Marriott International Reveals Asia Pacific's Future of Food
Oct 06, 2026 12:00 AM · prnewswire.com
THE RITZ-CARLTON NAPLES, TIBURÓN REVEALS TRANSFORMED RESORT AND DYNAMIC CULINARY CONCEPTS
Oct 05, 2026 01:44 PM · prnewswire.com
Lisata subsidiary Marea treats first patient in MAR002 acromegaly trial
Oct 05, 2026 05:57 AM · proactiveinvestors.com
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly
Oct 05, 2026 04:00 AM · globenewswire.com
Forget Inflation: Funflation Is Here and These ETFs Are Riding on It
Sep 28, 2026 06:56 AM · zacks.com
Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026
Sep 24, 2026 04:00 AM · globenewswire.com
Allworth Financial LP Has $5.55 Million Stock Holdings in Marriott International, Inc. $MAR
Sep 09, 2026 11:54 PM · defenseworld.net
Marriott International, Inc. (MAR) Presents at Bank of America Gaming and Lodging Conference 2026 Transcript
Sep 09, 2026 07:57 AM · seekingalpha.com
The Ritz-Carlton Yacht Collection Introduces Its Summer 2028 Mediterranean & Northern Europe Season
Sep 09, 2026 05:00 AM · prnewswire.com
California State Teachers Retirement System Has $42.45 Billion Position in Marriott International, Inc. $MAR
Sep 07, 2026 01:16 AM · defenseworld.net